| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |